Truist Financial’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-209,864
Closed -$655K 2626
2025
Q1
$655K Sell
209,864
-1,195
-0.6% -$4.2K ﹤0.01% 1724
2024
Q4
$834K Sell
211,059
-81,121
-28% -$285K ﹤0.01% 1629
2024
Q3
$1.18M Buy
292,180
+1,120
+0.4% +$3.91K ﹤0.01% 1450
2024
Q2
$742K Hold
291,060
﹤0.01% 1752
2024
Q1
$1.3M Hold
291,060
﹤0.01% 1491
2023
Q4
$1.37M Hold
291,060
﹤0.01% 1452
2023
Q3
$1.41M Sell
291,060
-75,000
-20% -$462K ﹤0.01% 1408
2023
Q2
$2.2M Sell
366,060
-66,941
-15% -$317K ﹤0.01% 1217
2023
Q1
$1.35M Hold
433,001
﹤0.01% 1410
2022
Q4
$1.12M Hold
433,001
﹤0.01% 1498
2022
Q3
$918K Hold
433,001
﹤0.01% 1533
2022
Q2
$1.15M Sell
433,001
-16,273
-4% -$43.3K ﹤0.01% 1474
2022
Q1
$1.19M Buy
+449,274
New +$1.47M ﹤0.01% 1547

Other funds holding EVLV

Truist Financial's EVLV Position: Q2 2025 in Review

Truist Financial sold out of Evolv Technologies (EVLV) in Q2 2025, closing a stake of 209,864 shares — an estimated $655K sold.

Truist Financial first reported a position in EVLV in Q1 2022 and held it in 13 quarters. The position peaked at $2.2M in Q2 2023. 213 funds tracked by Wall St. Rank hold EVLV as of Q2 2025.

  • Truist Financial reported no remaining Evolv Technologies position as of Q2 2025 after selling out during the quarter.
  • Truist Financial sold 209,864 Evolv Technologies shares in Q2 2025, an estimated $655K.
  • Truist Financial first reported a position in Evolv Technologies in Q1 2022 and held it in 13 quarters.
  • Truist Financial's Evolv Technologies position peaked at $2.2M in Q2 2023.
  • 213 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2025.

Based on Truist Financial's 13F filing for Q2 2025, filed 18 Jul 2025.